Tanihara, Hidenobu http://orcid.org/0000-0002-0356-7411
Yamamoto, Tetsuya http://orcid.org/0000-0001-6683-0144
Aihara, Makoto http://orcid.org/0000-0001-6810-0583
Koizumi, Noriko http://orcid.org/0000-0002-6940-1334
Fukushima, Atsuki http://orcid.org/0000-0002-6350-2599
Kawakita, Koji
Kojima, Satoshi
Nakamura, Toka
Suganami, Hideki http://orcid.org/0000-0001-9130-0137
Tagawa, Yoshitsugu
Watanabe, Hiroki
Shimizu, Kiyoshi
Iwasaki, Miki
Matsuzaki, Sakae
Ueda, Hiroko
Okayama, Ryoko
Matsuoka, Osamu
Hashida, Setsuko
Kobayashi, Sachi Amaki
Kiyosawa, Motohiro
Asai, Yuko
Nakajima, Toru
Yoshimura, Yuzuru
Sakai, Takao
Nomura, Ryoji
Inoue, Satoshi
Hayashi, Ken
Watanabe, Junko
Kawabata, Hidehito
Muramatsu, Tomoyuki
Arai, Mikki
Migita, Masayoshi
,
Funding for this research was provided by:
Kowa Company
Article History
Received: 23 August 2023
Revised: 9 January 2024
Accepted: 20 January 2024
First Online: 2 March 2024
Declarations
:
: The study was conducted in compliance with the principles of the Declaration of Helsinki and Good Clinical Practice guidelines. The protocol was approved by the Medical Corporation Heishinkai OPHAC Hospital IRB, Medical Corporation Cattleyakai Dr. Mano Medical Clinic IRB, Medical Corporation Shintokai Yokohama Minoru Clinic Institutional Review Board, Review Board of Human Rights and Ethics for Clinical Studies Institutional Review Board, and the ShinAkasaka Clinic Institutional Review Board (now known as the ShinAkasaka Clinic Aoyama Institutional Review Board). This study is registered with the Japan Registry of Clinical Trials (jRCT identifier: jRCT2080225063).
: Written informed consent for study participation was obtained from all subjects prior to study entry.
: Subjects signed informed consent regarding the publication of their data.
: All named authors attest that they meet the four criteria of authorship, as defined by the International Committee of Medical Journal Editors (ICMJE). All authors have participated sufficiently in the work and accept public responsibility for the appropriate portions of the content, as well as accepting responsibility for the integrity of their co-authors.
: This manuscript is based on work that was previously presented as an abstract at the 127th Annual Meeting of the Japanese Ophthalmological Society (6–9 April 2023; Tokyo, Japan).
: Hidenobu Tanihara has received consulting fees, lecture fees, financial support and drugs from Kowa Company, Ltd. Tetsuya Yamamoto has received consulting fees from Alcon Japan, Allergan Japan, Kowa Company, Ltd. and Santen Pharmaceutical; board membership fees from Kowa Company, Ltd., Otsuka Pharmaceutical, Rohto Pharmaceutical and Santen Pharmaceutical; financial support from Pfizer Japan, Otsuka Pharmaceutical, Santen Pharmaceutical and Senju Pharmaceutical; and lecture fees from Johnson & Johnson, Kowa Company, Ltd., Pfizer Japan, Nitto Medic, Novartis, Otsuka Pharmaceutical, Santen Pharmaceutical, Senju Pharmaceutical and Viatris. Makoto Aihara has received consulting fees from Santen Pharmaceutical, Senju Pharmaceutical, Alcon Japan, Pfizer Japan, Kowa Company, Ltd., Otsuka Pharmaceutical, Wakamoto Pharmaceutical, HOYA, Glaukos, IRIDEX, CREWT Medical Systems, Inc. and Astellas Pharmaceutical; financial support from Santen Pharmaceutical, Senju Pharmaceutical, Alcon Japan, Novartis, Pfizer Japan, Kowa Company, Ltd., Otsuka Pharmaceutical, Wakamoto Pharmaceutical, Johnson & Johnson, Glaukos, TOMEY, Ono Pharmaceutical, CREWT Medical Systems, Inc. and Sato Pharmaceutical; and lecture and travel fees and drugs from Santen Pharmaceutical, Senju Pharmaceutical, Alcon Japan, Novartis, Pfizer Japan, Kowa Company, Ltd., Otsuka Pharmaceutical, Johnson & Johnson, HOYA, Glaukos, TOMEY, IRIDEX, CREWT Medical Systems, Inc., CANON, Carl Zeiss Meditec and Sato Pharmaceutical. Noriko Koizumi has received consulting fees from Kowa Company, Ltd. and M's Science Corporation; lecture fees from Kowa Company, Ltd., Senju Pharmaceutical and Santen Pharmaceutical; and financial support from ActualEyes Inc. Atsuki Fukushima received consulting fees from Johnson & Johnson, Kowa Company, Ltd. and Santen Pharmaceutical; and lecture fees from Santen Pharmaceutical, Senju Pharmaceutical, Novartis, Johnson & Johnson, Tanabe-Mitsubishi and Rohto-nitten. Koji Kawakita, Satoshi Kojima, Toka Nakamura and Hideki Suganami are employees of Kowa Company, Ltd.